CPhI & P-MEC China moves to December to enable international attendance

21 Apr 2020

Date alteration taken at the request of exhibitors to ensure the international character of China’s largest pharma exhibition.

CPhI & P-MEC China 2020 will now take place on 16–18 December 2020 at SNIEC in Shanghai (rescheduled from 22–24 June 2020).

CPhI & P-MEC China moves to December to enable international attendance

The organizers secured the new date at the request of exhibitors to ensure the event’s continued international character. Nearly one quarter of CPhI & P-MEC China’s attendees come from international markets, and its global audience is a key component to many companies’ strategies in the region.

The new date will provide greater access to international audiences; at present, strict travel restrictions remain in place for all intentional visitors to China in response to COVID-19.

“By moving the event to a December date, we provide far greater flexibility and planning time for international executives. CPhI & P-MEC China has grown massively in the last few years and it remains the only truly international pharma ingredients and supply chain event in China, with 20,300+ overseas visits. Rather than host a domestic-only event, we, therefore, responded to the needs of our stakeholders, moving to a time when the event's unique international pedigree can be better maintained,” commented Orhan Caglayan, Brand Director Pharma Portfolio at Informa Markets.

Content and conference programmes will run at the rescheduled exhibition, with an updated agenda to be made available later in the year.

Caglayan added: “It’s our absolute priority to follow government advice globally and deliver safe and successful events. But we also want to take a proactive approach so that we can ensure the integrity and quality of the platforms we provide for both exhibitors and visitors.”

Read More

Related news

Pharmapack expert recommends holistic approach to sustainability

Pharmapack expert recommends holistic approach to sustainability

18 May 2020

Although the industry might be 30% along its sustainability journey, greater interoperability is needed from materials to devices.

Read more 
Rescheduled CPhI South East Asia moved to November

Rescheduled CPhI South East Asia moved to November

4 May 2020

Second postponement will provide improved confidence and market conditions for exhibitors and visitors.

Read more 
New technologies for solid dosage forms from Syntegon

New technologies for solid dosage forms from Syntegon

28 Apr 2020

Syntegon's new coater series can handle tablets with highly potent active ingredients.

Read more 
2020 CPhI Pharma Awards are open for entries

2020 CPhI Pharma Awards are open for entries

21 Apr 2020

Submit your entry before 1 July 2020!

Read more 
The future of liquid pharmaceutical processing on show ... virtually!

The future of liquid pharmaceutical processing on show ... virtually!

20 Apr 2020

Syntegon to showcase flexible solutions for small and microbatches, new developments for liquid filling and assembly, as well as AI-enhanced product safety.

Read more 
CPhI announces new pharma events calendar for 2020

CPhI announces new pharma events calendar for 2020

17 Mar 2020

Organizers secure three new dates for events in Japan, South East Asia and North America in response to COVID-19.

Read more 
CPhI Japan 2020 Postponed

CPhI Japan 2020 Postponed

27 Feb 2020

Rescheduling will ensure all stakeholders can take part in a successful exhibition and conference.

Read more 
The game is on for connected devices

The game is on for connected devices

20 Feb 2020

The future of value-added medicines will see gamification transforming the engagement of therapies.

Read more 
CPhI South East Asia rescheduled for July 2020

CPhI South East Asia rescheduled for July 2020

18 Feb 2020

Event move ensures extra precautions and safety measures taken

Read more 
Report predicts booming ASEAN generics export market for 2020

Report predicts booming ASEAN generics export market for 2020

13 Feb 2020

The changing opportunities are attributed to rising GMP standards and increased regional harmonization.

Read more